Fig. 3From: Immune-related lncRNAs signature and radiomics signature predict the prognosis and immune microenvironment of glioblastoma multiformeDifferentially enriched Reactome pathways. A Differentially enriched Reactome pathways using lncRNAs signature (P < 0.05). B Differentially enriched Reactome pathways using radiomics signature (P < 0.05)Back to article page